CORT Corcept Therapeutics Incorporated

$70.33

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and markets drugs for the treatment of severe metabolic, cancer, and psychiatric disorders in the United States. The company is headquartered in Menlo Park, California.

Website: https://www.corcept.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1088856
Address
149 COMMONWEALTH DRIVE, MENLO PARK, CA, US
Valuation
Market Cap
$6.57B
P/E Ratio
50.60
PEG Ratio
0.61
Price to Book
9.66
Performance
EPS
$1.23
Dividend Yield
—
Profit Margin
20.90%
ROE
23.80%
Technicals
50D MA
$65.29
200D MA
$50.97
52W High
$117.33
52W Low
$20.84
Fundamentals
Shares Outstanding
106M
Target Price
$143.25
Beta
0.14

CORT EPS Estimates vs Actual

● Estimated
● Actual

CORT News & Sentiment

Aug 01, 2025 • Zacks Commentary NEUTRAL
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
Corcept beats second-quarter earnings forecasts but misses the same for revenues. The company trims its 2025 revenue outlook.
Jul 31, 2025 • Zacks Commentary NEUTRAL
Corcept Therapeutics ( CORT ) Tops Q2 Earnings Estimates
Corcept (CORT) delivered earnings and revenue surprises of +26.09% and -4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 21, 2025 • Benzinga SOMEWHAT-BULLISH
Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years - Corcept Therapeutics ( NASDAQ:CORT )
Corcept Therapeutics CORT has outperformed the market over the past 5 years by 19.89% on an annualized basis producing an average annual return of 34.36%. Currently, Corcept Therapeutics has a market capitalization of $7.51 billion.
Jul 17, 2025 • Benzinga SOMEWHAT-BULLISH
What's Driving the Market Sentiment Around Corcept Therapeutics? - Corcept Therapeutics ( NASDAQ:CORT )
Corcept Therapeutics's CORT short percent of float has fallen 9.51% since its last report. The company recently reported that it has 11.45 million shares sold short, which is 14.55% of all regular shares that are available for trading.
Jul 17, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Madrigal ( MDGL ) Moves 10.9% Higher: Will This Strength Last?
Madrigal (MDGL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Jul 15, 2025 • Zacks Commentary NEUTRAL
Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
CORT's relacorilant combo targets platinum-resistant ovarian cancer in new NDA, backed by positive ROSELLA study data.
Sentiment Snapshot

Average Sentiment Score:

0.209
50 articles with scored sentiment

Overall Sentiment:

Bullish

CORT Reported Earnings

Apr 29, 2025
Mar 31, 2025 (Post market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Feb 13, 2025
Dec 31, 2024 (Post market)
-0.16 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.42
  • Whisper: —
  • Surprise %: -38.6%
Oct 30, 2024
Sep 30, 2024 (Post market)
0.13 Surprise
  • Reported EPS: $0.41
  • Estimate: $0.28
  • Whisper: —
  • Surprise %: 46.4%
Jul 29, 2024
Jun 30, 2024 (Post market)
0.09 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.23
  • Whisper: —
  • Surprise %: 39.1%
May 01, 2024
Mar 31, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: 13.6%
Feb 15, 2024
Dec 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.26
  • Whisper: —
  • Surprise %: 7.7%
Nov 01, 2023
Sep 30, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: 27.3%
Aug 02, 2023
Jun 30, 2023 (Post market)
0.1 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.15
  • Whisper: —
  • Surprise %: 66.7%
May 03, 2023
Mar 31, 2023 (Post market)
-0.05 Surprise
  • Reported EPS: $0.14
  • Estimate: $0.19
  • Whisper: —
  • Surprise %: -26.3%

Financials